This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Fortis Healthcare board to review September results and debenture changes
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty Midcap 150 and 2.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On November 5, 2026, Fortis Healthcare's board will approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. It will also alter rights and terms, including interest dates, for 155,000 listed non-convertible debentures with face value INR 100,000 each and total value up to INR 1,550 crore. Trading remains closed until 48 hours after results.
The results may move the share price, while debenture changes could affect debt costs and investor perceptions. No performance figures are provided yet.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹2,735 Cr | ₹2,331 Cr | +17.3% |
| Operating profit | ₹416.6 Cr | ₹375.6 Cr | +10.9% |
| Profit after tax | ₹320.5 Cr | ₹328.8 Cr | −2.5% |
| EBITDA margin | 22.9% | 24.9% | −2.0 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.